SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-24-046454
Filing Date
2024-04-22
Accepted
2024-04-22 16:28:18
Documents
5
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 DEF 14A tsbx_proxy_2024.htm DEF 14A 650851
2 GRAPHIC img156223387_0.jpg GRAPHIC 21584
3 GRAPHIC img156223387_1.jpg GRAPHIC 21584
4 GRAPHIC img156223387_2.jpg GRAPHIC 1330657
5 GRAPHIC img156223387_3.jpg GRAPHIC 146559
  Complete submission text file 0000950170-24-046454.txt   2744162
Mailing Address 9310 ATHENA CIRCLE, SUITE 300 LA JOLLA CA 92037
Business Address 9310 ATHENA CIRCLE, SUITE 300 LA JOLLA CA 92037 347-897-5988
Turnstone Biologics Corp. (Filer) CIK: 0001764974 (see all company filings)

IRS No.: 832909368 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-41747 | Film No.: 24861513
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)